{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/5fa6e85678bc150948ccfeb4/5fa6e85d4a2a5c52d1e331c0?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Clinical Perspectives on Barriers To HBV Care","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/5fa6e85678bc150948ccfeb4/1607726494592-952f9820523aa519010e25ad6a9860eb.jpeg?height=200","description":"<p>In this podcast follow-up to their recent <em>e</em>ViralHepatitis Review newsletter issue (Vol. 6, No. 5), Dr. Mandana Khalili and Dr. Michele Tana from the University of California, San Francisco discuss how their analysis of the newer published information can impact clinical practice. </p><p>\n</p><p>Take our <a href=\"https://elit.dkbmed.com/issues/26/test\">post-test</a> to claim CME credits.  </p><p>\n</p><p>To read a companion newsletter   <a href=\"https://elit.dkbmed.com/issues/21\">click here</a>  </p><p><br></p>","author_name":"eViralHepatitis Review"}